We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
CLBIO.ST

Price
8.64
Stock movement down
-0.02 (-0.23%)
Company name
Corline Biomedical AB
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Biotechnology
Market cap
211.60M
Ent value
212.81M
Price/Sales
15.11
Price/Book
2.50
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
9.71
PEG
-
EPS growth
-28.02%
1 year return
-26.47%
3 year return
-12.51%
5 year return
-16.28%
10 year return
-
Last updated: 2025-04-12

DIVIDENDS

CLBIO.ST does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales15.11
Price to Book2.50
EV to Sales15.19

FINANCIALS

Per share

Per share data
Current share count24.49M
EPS (TTM)-0.45
FCF per share (TTM)-0.46

Income statement

Income statement data
Revenue (TTM)14.01M
Gross profit (TTM)5.37M
Operating income (TTM)-9.07M
Net income (TTM)-9.63M
EPS (TTM)-0.45
EPS (1y forward)0.89

Margins

Margins data
Gross margin (TTM)38.32%
Operating margin (TTM)-64.78%
Profit margin (TTM)-68.77%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash7.33M
Net receivables0.00
Total current assets9.74M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets93.05M
Accounts payable3.77M
Short/Current long term debt0.00
Total current liabilities8.54M
Total liabilities8.54M
Shareholder's equity84.51M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-410.00K
Capital expenditures (TTM)9.48M
Free cash flow (TTM)-9.89M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-11.40%
Return on Assets-10.35%
Return on Invested Capital-11.40%
Cash Return on Invested Capital-11.70%

STOCK INFORMATION

Stock chart

Stock price data
Open8.80
Daily high8.80
Daily low8.20
Daily Volume2K
All-time high27.42
1y analyst estimate23.00
Beta0.42
EPS (TTM)-0.45
Dividend per share-
Ex-div date-
Next earnings date28 Apr 2025

Downside potential

Downside potential data
CLBIO.STS&P500
Current price drop from All-time high-68.49%-12.89%
Highest price drop-77.61%-56.47%
Date of highest drop28 Nov 20249 Mar 2009
Avg drop from high-45.55%-11.07%
Avg time to new high113 days12 days
Max time to new high1685 days1805 days
COMPANY DETAILS
CLBIO.ST (Corline Biomedical AB) company logo
Marketcap
211.60M
Marketcap category
Small-cap
Description
Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound. The company's products include Renaparin for use in the treatment of end stage renal failure; Cytoparin, a cell therapy that is used for the treatment of patients with type 1 diabetes; and CHC, which is used for the treatment of soft tissue injuries. The company was incorporated in 1991 and is based in Uppsala, Sweden.
Employees
13
Website
https://www.corline.se
Investor relations
-
SEC filings
CLBIO.ST SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved